カテゴリー： Allied Market Research, 世界, 医療/バイオ

終夜眠ポリグラフ検査（PSG）システムの世界市場2022-2031：機会分析・産業予測

◆英語タイトル：Ambulatory Polysomnography (Psg) Systems Market By Product (Up to 12 Channel PSG Systems, Up to 24 Channel PSG Systems, Up to 32 Channel PSG Systems, Above 32 Channel PSG Systems), By Application (Obstructive Sleep, Apnea Narcolepsy, Chronic Insomnia, Others), By End-user (Hospitals, Sleep Laboratories, Home Care Settings): Global Opportunity Analysis and Industry Forecast, 2022-2031

Allied Market Researchが発行した調査報告書（ALD23SEP149）◆商品コード：ALD23SEP149
◆発行会社（リサーチ会社）：Allied Market Research
◆発行日：2023年5月
◆ページ数：280
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：生命科学
◆販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥521,220見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥836,580見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,401,600見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

終夜眠ポリグラフ検査（PSG）システムの世界市場は、2022年から2031年にかけてCAGR 6.0％で2021年の3億2,700万ドルから成長し、2031年までに5億7,070万ドルを獲得すると予測されています。終夜眠ポリグラフ検査（Amb-PSG）は、タイプII PSGとしても知られ、睡眠段階を特徴付け、覚醒、総睡眠時間（TST）、正確な呼吸障害指数（RDI）を定量化することで、さまざまな睡眠障害を特定するために使用できます。終夜眠ポリグラフ検査（PSG）システムは、その利点から、さまざまな睡眠障害を患う患者の間で高い需要があります。これが、終夜眠ポリグラフ検査（PSG）システム市場を促進しています。

人口の大多数、特に地方では、睡眠時無呼吸症候群の危険性について知らされていません。睡眠障害が治療されないまま放置されると、心不全、脳卒中、高血圧、糖尿病、肥満などの慢性疾患につながる可能性があります。その結果、血圧のコントロール不能、心臓発作、腎臓の血管の弱化や制限、動脈瘤などの大きな健康問題を引き起こす可能性があります。睡眠障害に対する人々の認識不足は、近い将来、終夜眠ポリグラフ検査（PSG）システム市場の成長を妨げると予想されます。
睡眠ケア事業における技術改善は、この市場の推進力として特定できます。終夜眠ポリグラフ検査（PSG）システム市場は、ポータブルデバイス、スマートフォンアプリケーション、遠隔医療など、数多くの革新的な技術によって着実に成長しています。Nox MedicalのNox A1s PSGのようなワイヤレスでポータブルな睡眠ポリグラフ検査システムは、研究開発の恩恵を受けています。ワイヤレス機能は、診断中に患者が自由に動けるようにすることで、患者に開放感を与えます。これは、終夜眠ポリグラフ検査（PSG）システム市場の成長に有益な影響を与えるでしょう。

世界市場はCOVID-19パンデミックの発生によって恩恵を受けました。COVID-19パンデミックの結果、睡眠障害に苦しむ患者数が増加した結果、主要参加者は大幅な収益増を主張しました。世論調査によると、回答者の70％がCOVID-19の流行開始以来、1つ以上の新たな睡眠問題を経験し、睡眠時無呼吸装置の使用増加につながりました。この結果、PSGシステムの各事業者は、臨床的に認定された、患者の自宅から遠隔操作で利用できるロータッチCPAPマスク選択ツールを発売しました。

本レポートに掲載されている主要企業には、Koninklijke Philips N.V.、Natus Medical Incorporated、日本光電工業株式会社、Nox Medical、Löwenstein Medical Technology GmbH + Co. KG.、neurosoft、Cadwell Industries Inc.、SOMNOmedics GmbH、Compumedics Limited、Neurovirtual / Sleepvirtualなどがあります。

ステークホルダーにとっての主なメリット
本レポートは、2021年から2031年までの終夜眠ポリグラフ検査（PSG）システム市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、終夜眠ポリグラフ検査（PSG）システム市場の有力な市場機会を特定します。
主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を行い、サプライヤーとバイヤーのネットワークを強化できるようにします。
終夜眠ポリグラフ検査（PSG）システム市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
終夜眠ポリグラフ検査（PSG）システム市場の細分化に関する詳細な分析は、市場機会を決定するのに役立ちます。
市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
地域別および世界別の終夜眠ポリグラフ検査（PSG）システム市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

主な市場セグメント
製品別
最大12チャンネルのPSGシステム
最大24チャンネルのPSGシステム
最大32チャンネルPSGシステム
32チャンネル以上

アプリケーション別
閉塞性睡眠
無呼吸 ナルコレプシー
慢性不眠症
その他

エンドユーザー別
病院
睡眠研究所
在宅ケア

地域別
北米
米国
カナダ
メキシコ
ヨーロッパ
ドイツ
イギリス
フランス
スペイン
イタリア
その他のヨーロッパ
アジア太平洋
中国
日本
インド
韓国
オーストラリア
その他のアジア太平洋地域
LAMEA
ブラジル
アラブ首長国連邦
サウジアラビア
南アフリカ
その他の地域

主要市場プレイヤー
○ Cadwell Industries Inc.
○ Compumedics Limited
○ Compumedics Limited
○ Koninklijke Philips N.V.
○ Löwenstein Medical Technology GmbH + Co. KG.
○ Natus Medical Incorporated
○ neurosoft
○ Nihon Kohden Corporation
○ Nox Medical
○ SOMNOmedics GmbH

第1章：イントロダクション
第2章：エグゼクティブサマリー
第3章：市場概要
第4章：終夜眠ポリグラフ検査（PSG）システム市場、製品別
第5章：終夜眠ポリグラフ検査（PSG）システム市場、用途別
第6章：終夜眠ポリグラフ検査（PSG）システム市場、エンドユーザー別
第7章：終夜眠ポリグラフ検査（PSG）システム市場、地域別
第8章：競争状況
第9章：企業情報

❖ レポートの目次 ❖

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.4. Market dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
3.5. COVID-19 Impact Analysis on the market
3.6. Average Selling Price
3.7. Brand Share Analysis
3.8. Key Regulation Analysis
3.9. Market Share Analysis
3.10. Patent Landscape
3.11. Regulatory Guidelines
3.12. Value Chain Analysis
CHAPTER 4: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT
4.1. Overview
4.1.1. Market size and forecast
4.2. Up to 12 Channel PSG Systems
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Up to 24 Channel PSG Systems
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Up to 32 Channel PSG Systems
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
4.5. Above 32 Channel PSG Systems
4.5.1. Key market trends, growth factors and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market share analysis by country
CHAPTER 5: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Obstructive Sleep
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Apnea Narcolepsy
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Chronic Insomnia
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Others
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Sleep Laboratories
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Home Care Settings
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Product
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End-user
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Product
7.2.5.1.3. Market size and forecast, by Application
7.2.5.1.4. Market size and forecast, by End-user
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Product
7.2.5.2.3. Market size and forecast, by Application
7.2.5.2.4. Market size and forecast, by End-user
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Product
7.2.5.3.3. Market size and forecast, by Application
7.2.5.3.4. Market size and forecast, by End-user
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Product
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End-user
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Product
7.3.5.1.3. Market size and forecast, by Application
7.3.5.1.4. Market size and forecast, by End-user
7.3.5.2. UK
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Product
7.3.5.2.3. Market size and forecast, by Application
7.3.5.2.4. Market size and forecast, by End-user
7.3.5.3. France
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Product
7.3.5.3.3. Market size and forecast, by Application
7.3.5.3.4. Market size and forecast, by End-user
7.3.5.4. Spain
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Product
7.3.5.4.3. Market size and forecast, by Application
7.3.5.4.4. Market size and forecast, by End-user
7.3.5.5. Italy
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Product
7.3.5.5.3. Market size and forecast, by Application
7.3.5.5.4. Market size and forecast, by End-user
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Product
7.3.5.6.3. Market size and forecast, by Application
7.3.5.6.4. Market size and forecast, by End-user
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Product
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End-user
7.4.5. Market size and forecast, by country
7.4.5.1. China
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Product
7.4.5.1.3. Market size and forecast, by Application
7.4.5.1.4. Market size and forecast, by End-user
7.4.5.2. Japan
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Product
7.4.5.2.3. Market size and forecast, by Application
7.4.5.2.4. Market size and forecast, by End-user
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Product
7.4.5.3.3. Market size and forecast, by Application
7.4.5.3.4. Market size and forecast, by End-user
7.4.5.4. South Korea
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Product
7.4.5.4.3. Market size and forecast, by Application
7.4.5.4.4. Market size and forecast, by End-user
7.4.5.5. Australia
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Product
7.4.5.5.3. Market size and forecast, by Application
7.4.5.5.4. Market size and forecast, by End-user
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Product
7.4.5.6.3. Market size and forecast, by Application
7.4.5.6.4. Market size and forecast, by End-user
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Product
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End-user
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Product
7.5.5.1.3. Market size and forecast, by Application
7.5.5.1.4. Market size and forecast, by End-user
7.5.5.2. United Arab Emirates
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Product
7.5.5.2.3. Market size and forecast, by Application
7.5.5.2.4. Market size and forecast, by End-user
7.5.5.3. Saudi Arabia
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Product
7.5.5.3.3. Market size and forecast, by Application
7.5.5.3.4. Market size and forecast, by End-user
7.5.5.4. South Africa
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Product
7.5.5.4.3. Market size and forecast, by Application
7.5.5.4.4. Market size and forecast, by End-user
7.5.5.5. Rest of LAMEA
7.5.5.5.1. Key market trends, growth factors and opportunities
7.5.5.5.2. Market size and forecast, by Product
7.5.5.5.3. Market size and forecast, by Application
7.5.5.5.4. Market size and forecast, by End-user
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Koninklijke Philips N.V.
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.2. Natus Medical Incorporated
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.3. Nihon Kohden Corporation
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.4. Nox Medical
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.5. Löwenstein Medical Technology GmbH + Co. KG.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.6. neurosoft
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.7. Cadwell Industries Inc.
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.8. SOMNOmedics GmbH
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.9. Compumedics Limited
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.10. Compumedics Limited
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot

LIST OF TABLES
TABLE 01. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 02. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 12 CHANNEL PSG SYSTEMS, BY REGION, 2021-2031 ($MILLION)
TABLE 03. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 24 CHANNEL PSG SYSTEMS, BY REGION, 2021-2031 ($MILLION)
TABLE 04. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR UP TO 32 CHANNEL PSG SYSTEMS, BY REGION, 2021-2031 ($MILLION)
TABLE 05. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR ABOVE 32 CHANNEL PSG SYSTEMS, BY REGION, 2021-2031 ($MILLION)
TABLE 06. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 07. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR OBSTRUCTIVE SLEEP, BY REGION, 2021-2031 ($MILLION)
TABLE 08. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR APNEA NARCOLEPSY, BY REGION, 2021-2031 ($MILLION)
TABLE 09. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR CHRONIC INSOMNIA, BY REGION, 2021-2031 ($MILLION)
TABLE 10. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 11. GLOBAL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 12. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR SLEEP LABORATORIES, BY REGION, 2021-2031 ($MILLION)
TABLE 14. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET FOR HOME CARE SETTINGS, BY REGION, 2021-2031 ($MILLION)
TABLE 15. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 16. NORTH AMERICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 17. NORTH AMERICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 18. NORTH AMERICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 19. NORTH AMERICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 20. U.S. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 21. U.S. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 22. U.S. AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 23. CANADA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 24. CANADA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 25. CANADA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 26. MEXICO AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 27. MEXICO AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 28. MEXICO AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 29. EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 30. EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 31. EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 32. EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 33. GERMANY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 34. GERMANY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 35. GERMANY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 36. UK AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 37. UK AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 38. UK AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 39. FRANCE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 40. FRANCE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 41. FRANCE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 42. SPAIN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 43. SPAIN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 44. SPAIN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 45. ITALY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 46. ITALY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 47. ITALY AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 48. REST OF EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 49. REST OF EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 50. REST OF EUROPE AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 51. ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 52. ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 53. ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 54. ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 55. CHINA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 56. CHINA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 57. CHINA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 58. JAPAN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 59. JAPAN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 60. JAPAN AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 61. INDIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 62. INDIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 63. INDIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 64. SOUTH KOREA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 65. SOUTH KOREA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 66. SOUTH KOREA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 67. AUSTRALIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 68. AUSTRALIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 69. AUSTRALIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 73. LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 74. LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 75. LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 76. LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 77. BRAZIL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 78. BRAZIL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 79. BRAZIL AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 80. UNITED ARAB EMIRATES AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 81. UNITED ARAB EMIRATES AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 82. UNITED ARAB EMIRATES AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 83. SAUDI ARABIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 84. SAUDI ARABIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 85. SAUDI ARABIA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 86. SOUTH AFRICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 87. SOUTH AFRICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 88. SOUTH AFRICA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 89. REST OF LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY PRODUCT, 2021-2031 ($MILLION)
TABLE 90. REST OF LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY APPLICATION, 2021-2031 ($MILLION)
TABLE 91. REST OF LAMEA AMBULATORY POLYSOMNOGRAPHY (PSG) SYSTEMS MARKET, BY END-USER, 2021-2031 ($MILLION)
TABLE 92. KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
TABLE 93. KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
TABLE 94. NATUS MEDICAL INCORPORATED: KEY EXECUTIVES
TABLE 95. NATUS MEDICAL INCORPORATED: COMPANY SNAPSHOT
TABLE 96. NIHON KOHDEN CORPORATION: KEY EXECUTIVES
TABLE 97. NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT
TABLE 98. NOX MEDICAL: KEY EXECUTIVES
TABLE 99. NOX MEDICAL: COMPANY SNAPSHOT
TABLE 100. LÖWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG.: KEY EXECUTIVES
TABLE 101. LÖWENSTEIN MEDICAL TECHNOLOGY GMBH + CO. KG.: COMPANY SNAPSHOT
TABLE 102. NEUROSOFT: KEY EXECUTIVES
TABLE 103. NEUROSOFT: COMPANY SNAPSHOT
TABLE 104. CADWELL INDUSTRIES INC.: KEY EXECUTIVES
TABLE 105. CADWELL INDUSTRIES INC.: COMPANY SNAPSHOT
TABLE 106. SOMNOMEDICS GMBH: KEY EXECUTIVES
TABLE 107. SOMNOMEDICS GMBH: COMPANY SNAPSHOT
TABLE 108. COMPUMEDICS LIMITED: KEY EXECUTIVES
TABLE 109. COMPUMEDICS LIMITED: COMPANY SNAPSHOT
TABLE 110. COMPUMEDICS LIMITED: KEY EXECUTIVES
TABLE 111. COMPUMEDICS LIMITED: COMPANY SNAPSHOT

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 終夜眠ポリグラフ検査（PSG）システムの世界市場2022-2031：機会分析・産業予測(Ambulatory Polysomnography (Psg) Systems Market By Product (Up to 12 Channel PSG Systems, Up to 24 Channel PSG Systems, Up to 32 Channel PSG Systems, Above 32 Channel PSG Systems), By Application (Obstructive Sleep, Apnea Narcolepsy, Chronic Insomnia, Others), By End-user (Hospitals, Sleep Laboratories, Home Care Settings): Global Opportunity Analysis and Industry Forecast, 2022-2031)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 電動式人工補綴の世界市場2021-2031：機会分析・産業予測
  • 酸素ボンベ＆濃縮器の世界市場2021-2031：機会分析・産業予測
  • 遺伝子合成の世界市場2021-2031：機会分析・産業予測
  • 体外受精（IVF）顕微鏡の世界市場2021-2031：機会分析・産業予測
  • がんモノクローナル抗体の世界市場2021-2031：機会分析・産業予測

    • ◆H&Iグローバルリサーチのお客様（例）◆